Abstract
Aldose Reductase (AR), the key enzyme of the polyol pathway catalyzes the reduction of glucose to sorbitol using nicotinamide adenine dinucleotide phosphate as an essential cofactor, has been demonstrated to play an important role in the pathogenesis of diabetic complications. Self Organizing Molecular Field Analysis (SOMFA), a novel threedimensional quantitative structure activity relationship (3D-QSAR) method has been used in present case to study the correlation between the molecular properties and the aldose reductase inhibitory activities on a series of 5-arylidine-2, 4- thiazolidinedione. SOMFA calculations for both shape and electrostatic potentials were carried out. The master grid maps derived from the best model has been used to display the contribution of both electrostatic and shape potential. The statistical results showed good cross-validated r2 CV, non cross-validated r2, F-test set and significant predictive ability indicated by r2 pred. All analysis of SOMFA models may provide useful information in the design of new aldose reductase inhibitors with improved spectrum of activity for management of diabetic complications.
Keywords: Aldose reductase, Diabetic complications, Diabetes, Thiazolidinedione, 3D-QSAR, SOMFA
Medicinal Chemistry
Title: 3D-QSAR Studies on a Series of 5-Arylidine-2, 4-Thiazolidinediones as Aldose Reductase Inhibitors: A Self-Organizing Molecular Field Analysis Approach
Volume: 6 Issue: 1
Author(s): Suresh Thareja, Saurabh Aggarwal, Tilak Raj Bhardwaj and Manoj Kumar
Affiliation:
Keywords: Aldose reductase, Diabetic complications, Diabetes, Thiazolidinedione, 3D-QSAR, SOMFA
Abstract: Aldose Reductase (AR), the key enzyme of the polyol pathway catalyzes the reduction of glucose to sorbitol using nicotinamide adenine dinucleotide phosphate as an essential cofactor, has been demonstrated to play an important role in the pathogenesis of diabetic complications. Self Organizing Molecular Field Analysis (SOMFA), a novel threedimensional quantitative structure activity relationship (3D-QSAR) method has been used in present case to study the correlation between the molecular properties and the aldose reductase inhibitory activities on a series of 5-arylidine-2, 4- thiazolidinedione. SOMFA calculations for both shape and electrostatic potentials were carried out. The master grid maps derived from the best model has been used to display the contribution of both electrostatic and shape potential. The statistical results showed good cross-validated r2 CV, non cross-validated r2, F-test set and significant predictive ability indicated by r2 pred. All analysis of SOMFA models may provide useful information in the design of new aldose reductase inhibitors with improved spectrum of activity for management of diabetic complications.
Export Options
About this article
Cite this article as:
Thareja Suresh, Aggarwal Saurabh, Bhardwaj Tilak Raj and Kumar Manoj, 3D-QSAR Studies on a Series of 5-Arylidine-2, 4-Thiazolidinediones as Aldose Reductase Inhibitors: A Self-Organizing Molecular Field Analysis Approach, Medicinal Chemistry 2010; 6 (1) . https://dx.doi.org/10.2174/157340610791208718
DOI https://dx.doi.org/10.2174/157340610791208718 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
Current Medicinal Chemistry Patent Selections
Recent Patents on Biotechnology Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy
CNS & Neurological Disorders - Drug Targets Medicinal Chemistry of 2,2,4-Substituted Morpholines
Current Medicinal Chemistry Sirtuins as Possible Targets in Neurodegenerative Diseases
Current Drug Targets Purification of Paraoxonase Enzyme From the Sera of Patients with Behcet’s Disease and Analyzing the Effects of the Drugs Containing Imuran (Azathioprine), Prednisolone (Methylprednisolone) and Colchium (Colchicine)
Drug Metabolism Letters S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics Pathophysiology of Diabetic Dyslipidaemia
Current Vascular Pharmacology Reactivity-Based Drug Discovery Using Vitamin B6-Derived Pharmacophores
Mini-Reviews in Medicinal Chemistry Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Current Pharmaceutical Design Nanomedicine
Current Nanoscience Attenuating Diabetes: What Really Works?
Current Diabetes Reviews Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers Genetically-Modified Human Pluripotent Stem Cells: New Hopes for the Understanding and the Treatment of Neurological Diseases?
Current Gene Therapy Preface: Facing New Challenges in Cardiovascular Disease, When the Pressure Goes Up and the Pump Goes Astray
Recent Advances in Cardiovascular Drug Discovery (Discontinued) The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Role of AGEs in Diabetic Nephropathy
Current Pharmaceutical Design Scientific Basis for the Use of Indian Ayurvedic Medicinal Plants in the Treatment of Neurodegenerative Disorders: 1. Ashwagandha
Central Nervous System Agents in Medicinal Chemistry Aldose Reductase Inhibitors and Nanodelivery of Diabetic Therapeutics
Mini-Reviews in Medicinal Chemistry Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)